On March 19, the U.S. Food and Drug Administration announced that Boston Scientific notified it that the company has stopped shipping and is recalling all of its implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) that have not yet been implanted. Read more at http://www.fda.gov/Safety/MedWatch/SafetyInformationSafetyAlertsforHumanMedicalProducts/ucm205409.htm.
© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder